September 24, 2012

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2012 ACS

Patent Number: WO 2012093101
Title: Indole compounds or analogs thereof as complement factor D inhibitors useful for the
treatment of age-related macular degeneration and their preparation
Inventor(s): Altmann, Eva; Hommel, Ulrich; Lorthiois, Edwige Liliane Jeanne; Maibaum, Juergen Klaus; Ostermann, Nils; Quancard, Jean; Randl, Stefan Andreas; Simic, Oliver; Vulpetti, Anna; Rogel, Olivier
Patent Assignee(s): Novartis AG, Switz.
Source: PCT Int. Appl., 566pp. CODEN: PIXXD2
Language: English

Abstract:

The invention provides a compound of formula I: a method for manufacturing the compds. of the invention, and its therapeutic uses. The invention further provides a combination of pharmacol. active agents and a pharmaceutical composition  Compds. of formula I wherein Z1 is  C and N; Z2 is CR2 and N; C4 is CR4 and N; Z5 is CR5, N and N-oxide; Z6 is CR6, N and N- oxide; Z7 is CR7, N and N-oxide; each Z is independently C and N; L is NH, CH2 and CHR1; R1  is H, OH and amino; R2 is H and C1-6 alkyl; R3 is H, C1-4 alkyl, C1-4 hydroxyalkyl, etc.; R4 is H, halo and C1-6 alkyl; R5 and R6 are independently H, halo, OH, amino, etc.; R7 is H,  halo, C1-6 alkoxy, etc.; X1 is (un)substituted methylene and S; X2 is (un)substituted  methylene, S, O, NH, etc.; X1X2 may be taken together for form (un)substituted ethylene; X3  is (un)substituted C0-2 alkylene; X2X3 taken together to form N=CH, , N=C-C1-4 alkyl; G is  CONH, CH2NHSO2, CH2NHCO, etc.;R20is H and C1-6 alkyl; R21 is H, OH, halo, C1-6 alkyl, etc.;  R22 is H and C1-6 alkyl; Z is C1-6 alkyl, C1-6 haloalkyl, Ph, etc.; and with provisions; and  pharmaceutically acceptable salt thereof, are claimed.  Example compound II was prepared by  amidation of (2S,4R)-1-(1-carbamoyl-1H-indol-3-ylcarbamoyl)- 4-fluoropyrrolidine-2-carboxylic  acid with 3-chloro-2-fluorobenzylamine. All the invention compds. were evaluated for their  complement factor D inhibitory activity.  From the assay, it was determined that compound II  exhibited IC50 value of 7 nM.

Please note:  Titles and abstracts for patent records in CAplus are routinely enhanced to better describe the claimed invention. In this example, CAS enhanced both the abstract and title using additional information found in the patent. The original title of the PCT publication is Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (AMD). For the CAplus record, this title was enhanced to read Indole compounds or analogs thereof as complement factor D inhibitors useful for the treatment of age-related macular degeneration and their preparation.

 View the full-text here.

Recent News

       
    February 9, 2015 | Major New STN Release Delivers
    Essential Biomedical and Patent Content to IP
    Professionals
    
    January 26, 2015
 | Annual MEDLINE Reload on STN
    Features Enhanced Clinical Trial Information and the
    2015 MeSH Thesaurus
    
    January 23, 2015
 | STN Launches New Pricing
    Option for Information Brokers: Search Service
    Value Pricing
                               
  
                                                                     More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org